CTS Announces Third Quarter 2026 Results

CTS posts strong Q3 growth, lifts 2026 sales and earnings guidance.

What the company is saying

CTS Corporation reports a 5% year-over-year increase in Q3 2026 sales to $149.6 million, highlighting continued strength across a diversified portfolio. CEO Pratik Trivedi frames the results as evidence of 'disciplined execution,' emphasizing profitable growth, record margins, and robust cash generation. The company points to a 7% rise in diversified end-market sales, now comprising 60% of total sales, and modest 2% growth in transportation sales. The acquisition of Millar is positioned as a key step in advancing CTS's diversification, especially in the medical sector. CTS raises its 2026 sales guidance to $580–$590 million and its adjusted diluted EPS guidance to $2.78–$2.88, citing confidence in current market conditions. The announcement stresses improved operational performance and strategic progress, while acknowledging that non-GAAP forward-looking reconciliations are not provided due to forecasting challenges. The tone is confident, with an emphasis on both realised financial improvement and future growth potential.

What the data suggests

The disclosed numbers show clear operational and financial momentum. Sales rose 5% year-over-year to $149.6 million, with diversified end-market sales up 7% and now accounting for 60% of total revenue. Transportation sales increased 2%. Net income climbed to $17.8 million (11.9% of sales) from $13.7 million (9.6% of sales) a year earlier. Diluted EPS increased to $0.61 from $0.46, and adjusted diluted EPS reached $0.77, up from $0.60. Adjusted gross margin improved to 42.2% from 38.9%, and adjusted EBITDA margin rose to 24.7% from 23.8%. Operating cash flow was $43.5 million, up $14.5 million from $29.0 million in Q3 2025. The company’s raised 2026 guidance—sales of $580–$590 million and adjusted diluted EPS of $2.78–$2.88—reflects management’s confidence in sustaining this trajectory. The acquisition of Millar is presented as a strategic move, though its financial impact is not quantified in this release. The data supports the narrative of broad-based growth and margin improvement, with all key metrics moving in a positive direction.

Analysis

The announcement's tone is positive but proportionate to the disclosed, realised financial results. The majority of key claims are supported by concrete, year-over-year improvements in sales, net income, EPS, margins, and cash flow. Only two key claims are forward-looking (raised 2026 sales and EPS guidance), while the rest are realised and quantified. The acquisition of Millar is presented as completed, not merely planned, and there is no indication of a large capital outlay with deferred or uncertain returns. The CEO's language about 'profitable growth, record margins, and strong cash generation' is largely substantiated by the reported numbers, though the 'record' claim is not fully evidenced with multi-year data. Overall, the narrative closely matches the evidence, with no material exaggeration or narrative inflation.

Risk flags

• ●The company does not provide reconciliations for forward-looking non-GAAP financial measures, citing forecasting difficulty. This limits transparency on how adjusted EPS targets relate to GAAP results and could obscure the impact of one-off or non-recurring items.
• ●The financial impact of the Millar acquisition is not quantified in the release. Without detail on integration costs or expected contribution, investors cannot fully assess the risk or upside from this transaction.
• ●The claim of 'record margins' is not substantiated with multi-year historical data. While year-over-year margin improvement is clear, the absence of a longer-term context makes it difficult to evaluate the sustainability or true record-setting nature of current profitability.

Bottom line

CTS Corporation delivers a strong Q3 2026, with all key financial metrics—sales, net income, margins, and cash flow—showing year-over-year improvement. The company’s raised sales and adjusted EPS guidance for 2026 signals management’s confidence in sustained performance, with less than a quarter remaining in the year. The acquisition of Millar is positioned as a strategic diversification move, but its financial contribution remains unquantified, leaving some uncertainty about integration and future impact. The lack of non-GAAP reconciliations for forward-looking guidance is a transparency gap, though current realised results are robust and well-documented. Investors should focus on whether CTS can maintain margin gains and deliver on its upgraded guidance as year-end approaches. The most important takeaway is that CTS is executing on its diversification strategy while delivering tangible, near-term financial growth.

Announcement summary

(NYSE: CTS) CTS Corporation reported third quarter 2026 sales of $149.6 million, representing a 5% increase year-over-year. Diversified end-market sales grew 7% and now account for 60% of total sales. Transportation market sales increased 2% in the quarter. Net income for the third quarter was $17.8 million, or 11.9% of sales, compared to $13.7 million, or 9.6% of sales, in the third quarter of 2025. Diluted earnings per share (EPS) were $0.61, up from $0.46 in the prior year period. Adjusted gross margin reached 42.2%, an increase of 330 basis points from 38.9% in the third quarter of 2025. Adjusted EBITDA margin was 24.7%, up 90 basis points from 23.8% in the prior year quarter. Adjusted diluted EPS was $0.77, up from $0.60 in the third quarter of 2025. Operating cash flow for the quarter was $43.5 million, an increase of $14.5 million from $29.0 million in the third quarter of 2025. CTS completed the acquisition of Millar, advancing its diversification strategy, particularly in the medical end market. The company increased its 2026 sales guidance from a previous range of $565-$585 million to a new range of $580-$590 million. Adjusted diluted EPS guidance for 2026 was raised from a range of $2.55-$2.70 to $2.78-$2.88. CTS does not provide reconciliations of forward-looking non-GAAP financial measures to the most comparable GAAP measures due to the difficulty of forecasting certain items. CEO Pratik Trivedi stated that disciplined execution is delivering profitable growth, record margins, and strong cash generation. CTS scheduled a conference call for 10:00 a.m. (ET) on the day of the announcement, with access details provided online. A supplemental slide presentation and live audio webcast are available on the CTS investor website.

Disagree with this article?